Clinical Evidence on Kanna Therapy
Kanna Clinic distils peer-reviewed research on Sceletium tortuosum for practitioners and curious patients — clear summaries, cited sources, no hype.
What the Research Shows
Sceletium tortuosum has been studied for its serotonin-reuptake inhibiting and phosphodiesterase-4 inhibiting properties. Clinical trials show modest anxiolytic and mood-supporting effects at low doses. Kanna Clinic synthesises those findings into practitioner-readable summaries with full citations.
Dosing, Safety, and Contraindications
Current research suggests effective doses range from 25–50 mg of standardised extract. Key contraindications include concurrent SSRI or MAOI use. This site is a companion resource to kanna.clinic for patients seeking a deeper clinical perspective.
Frequently asked questions
- Is this site the same as kanna.clinic?
- Kannaclinic.com is a sister site to kanna.clinic, offering deeper practitioner-oriented evidence summaries and citations.
- Is kanna legal and safe to use?
- Sceletium tortuosum is legal in most countries and has a long traditional use history; always consult a clinician before starting.
- Who writes the evidence summaries?
- Summaries are prepared by researchers familiar with botanical pharmacology and reviewed against primary literature sources.
Get in touch
Practitioners with clinical questions or researchers wishing to contribute evidence summaries are welcome to reach out.
info@kannaclinic.com